The U.K.’s drug regulator is said to have started accelerated reviews of Covid-19 vaccines under development from Pfizer Inc. and AstraZeneca Plc, with Europe grappling to control a renewed surge in the disease. Global infections surpassed 45 million.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push